Harmony Biosciences
HRMY
#4991
Rank
C$2.50 B
Marketcap
C$43.25
Share price
1.82%
Change (1 day)
4.44%
Change (1 year)

Revenue for Harmony Biosciences (HRMY)

Revenue in 2025 (TTM): C$1.20 Billion

According to Harmony Biosciences's latest financial reports the company's current revenue (TTM ) is C$1.18 Billion. an increase over the revenue in the year 2024 that were of C$1.02 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Harmony Biosciences from 2019 to 2025

Annual revenue

Year Revenue Change
2025 C$1.18 B15.96%
2024 C$1.02 B32.86%
2023 C$0.77 B29.93%
2022 C$0.59 B52.63%
2021 C$0.38 B91.11%
2020 C$0.20 B2501.36%
2019 C$7.82 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
C$0.87 B-26.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C$0.3 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA